 We anticipate screening 200 patients in order to enroll and randomize 100 subjects. Subjects will be randomized 2:1 to the TheraGauzetobramycin or iodoform wick plain cotton wick, respectively. We anticipate 50 participants completing the study. The 50 retention rate is typical for emergency department populations. 